Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price fell 0.2% during trading on Thursday . The stock traded as low as $1.66 and last traded at $1.68. 8,909,557 shares were traded during mid-day trading, a decline of 64% from the average session volume of 25,071,973 shares. The stock had previously closed at $1.68.
Analyst Ratings Changes
Separately, Roth Mkm decreased their price target on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a report on Friday, October 11th.
View Our Latest Report on Tilray
Tilray Price Performance
The firm has a market capitalization of $1.27 billion, a PE ratio of -3.73 and a beta of 2.13. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The business's 50 day moving average is $1.71 and its two-hundred day moving average is $1.80.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. During the same period in the previous year, the firm posted ($0.10) EPS. The firm's revenue was up 13.0% compared to the same quarter last year. As a group, research analysts anticipate that Tilray Inc will post -0.14 EPS for the current year.
Hedge Funds Weigh In On Tilray
Large investors have recently modified their holdings of the company. Madrona Financial Services LLC bought a new position in Tilray during the first quarter valued at approximately $124,000. SpiderRock Advisors LLC bought a new stake in Tilray during the 1st quarter valued at $247,000. Private Advisor Group LLC raised its holdings in Tilray by 7.3% during the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company's stock valued at $434,000 after buying an additional 12,021 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company's stock valued at $6,699,000 after buying an additional 213,834 shares during the period. Finally, Capstone Investment Advisors LLC grew its holdings in Tilray by 320.9% in the 1st quarter. Capstone Investment Advisors LLC now owns 95,736 shares of the company's stock worth $236,000 after acquiring an additional 72,989 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.